Kingsview Wealth Management LLC Sells 35,893 Shares of Corteva, Inc. $CTVA

Kingsview Wealth Management LLC trimmed its holdings in Corteva, Inc. (NYSE:CTVA) by 75.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,479 shares of the company’s stock after selling 35,893 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Corteva were worth $769,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. increased its stake in shares of Corteva by 6,527.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after purchasing an additional 3,100,709 shares in the last quarter. Perpetual Ltd boosted its position in shares of Corteva by 78,688.5% in the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after purchasing an additional 2,612,459 shares in the last quarter. Amundi grew its stake in shares of Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after buying an additional 1,899,248 shares during the last quarter. Squarepoint Ops LLC increased its position in Corteva by 423.6% during the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after buying an additional 1,406,199 shares in the last quarter. Finally, Man Group plc increased its position in Corteva by 16,474.3% during the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock valued at $87,522,000 after buying an additional 1,286,317 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

CTVA stock opened at $77.71 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a market cap of $51.98 billion, a P/E ratio of 45.71, a price-to-earnings-growth ratio of 2.39 and a beta of 0.59. The stock’s fifty day moving average price is $81.32 and its 200-day moving average price is $74.68.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Analyst Ratings Changes

Several research firms have commented on CTVA. Royal Bank Of Canada boosted their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Rothschild & Co Redburn lifted their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Mizuho upped their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Finally, Citigroup increased their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.